Columbia Stock Gaps Down On Today's Open (CBRX)

NEW YORK ( TheStreet) -- Shares of Columbia Laboratories (Nasdaq: CBRX) were gapping down Monday morning with an open price 57.6% lower than Friday's closing price. The stock closed at $1.58 Friday and opened today's trading at 67 cents.

The average volume for Columbia has been 1.1 million shares per day over the past 30 days. Columbia has a market cap of $137.9 million and is part of the health care sector and drugs industry. Shares are down 36.8% year to date as of the close of trading on Friday.

Columbia Laboratories, Inc. engages in the research, development, and commercialization of women's healthcare and endocrinology products. It develops products by utilizing its bioadhesive drug delivery technologies. The company has a P/E ratio of 11.3, below the average drugs industry P/E ratio of 19.8 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Columbia as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, good cash flow from operations and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full Columbia Ratings Report.

Get more investment ideas from our investment research center.

Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.

null

More from Markets

Dow Tumbles as Trump Calls Off North Korea Summit

Dow Tumbles as Trump Calls Off North Korea Summit

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Stocks Could Easily Crater Into Memorial Day Weekend

Stocks Could Easily Crater Into Memorial Day Weekend

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Video: Here Is How Real Estate Investment Trusts Can Boost Your Portfolio

Celgene Shares Rise on Plans to Increase Stock Buybacks

Celgene Shares Rise on Plans to Increase Stock Buybacks